Las Vegas, NV -- (SBWIRE) -- 10/11/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Gilead Sciences, Inc. (NASDAQ:GILD), Cemex SAB de CV (ADR) (NYSE:CX), Morgan Stanley (NYSE:MS), Boston Scientific Corporation (NYSE:BSX)
Gilead Sciences, Inc. (NASDAQ:GILD) managed to keep its gain at 6.52% on above-normal volume of 15.24M shares. The stock settled at $62.74 after floating in a range of $61.15 to $62.80. Its latest price has reached market capitalization of $96.03 billion. Its 52-week range has been $32.07 to $64.74. Gilead Sciences, Inc. (Gilead) is a research-based biopharmaceutical company that discovers, develops and commercializes medicines.
For How Long GILD will fight for Profitability? Read This Trend Analysis report
Cemex SAB de CV (ADR) (NYSE:CX) traded up on a volume of 14.92 million, higher than its standard daily volume. Shares have gained 2.06% to $10.90. Over the last twelve months, the stock has gained 24.29% and faced a worst price of $7.95. Cemex SAB de CV (CEMEX) is a Mexico-based company principally engaged, through its subsidiaries, in the cement manufacturing.
For How Long CX’s Gloss will Attract Investors? Find out via this report
Morgan Stanley (NYSE:MS) settled 3.25% higher at $27.64 on above-normal volume of 14.47M shares during the last trading day. The stock has its 12-month high at $29.50 and 52-week low price was $15.95. It traded in a range of $27.02 to $27.70 during the last trading day. Morgan Stanley is a global financial services company that, through its subsidiaries and affiliates, provides its products and services to a range of clients and customers, including corporations, governments, financial institutions and individuals. The Company is a financial holding company.
Why Should Investors Buy MS After the Recent Fall? Just Go Here and Find Out
In the last trading session, Boston Scientific Corporation (NYSE:BSX) was up on low volume, trading at a volume of 13.94 M versus its average daily volume of 14.92 million shares. At $11.88, the stock has attained market capitalization of 15.95 billion. Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties.
Will BSX Continue To Move Higher? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)